Ahmad Nematollahi | Parasitology | Best Researcher Award

Prof. Dr. Ahmad Nematollahi | Parasitology | Best Researcher Award

Academic Member | University of Tabriz | Iran

Prof. Dr. Ahmad Nematollahiis a distinguished Professor at the University of Tabriz, Iran, specializing in Veterinary Parasitology. He earned his DVM in Veterinary Medicine from Urmia and his Ph.D. in Veterinary Parasitology from the University of Tehran. Over his academic career, he has contributed significantly to parasitology education through courses on nematodes, protozoa, arthropods, and helminth taxonomy. His administrative and teaching service spans more than three decades at the University of Tabriz, where he has supervised numerous master’s and doctoral theses on protozoan and helminthic infections in domestic animals. Dr. Nematollahi has published widely in national and international journals on subjects including Toxoplasma gondii, Sarcocystis, Eimeria, Haemonchus contortus, and Theileria species. His extensive conference participation across Asia and Europe underscores his active engagement in global veterinary research. Recognized multiple times as a superior researcher and teacher, he is also an accomplished author of textbooks in parasitology. Dr. Nematollahi has published 42 scientific documents, accumulating 495 citations and holds an h-index of 14

Profiles:  Scopus | Google Scholar | ORCID

Featured Publications

1. Nematollahi, A., Moghaddam, G., & Pourabad, R. F. (2009). Prevalence of Eimeria species among broiler chicks in Tabriz (Northwest of Iran). Munis Entomology & Zoology, 4(1), 53–58.
Cited by: 120

2. Hasanpour, A., Moghaddam, G. A., & Nematollahi, A. (2008). Biochemical, hematological, and electrocardiographic changes in buffaloes naturally infected with Theileria annulata. The Korean Journal of Parasitology, 46(4), 223–228.
Cited by: 109

3. Pourseif, M. M., Yousefpour, M., Aminianfar, M., Moghaddam, G., & Nematollahi, A. (2019). A multi-method and structure-based in silico vaccine designing against Echinococcus granulosus through investigating enolase protein. BioImpacts, 9(3), 131–144.
Cited by: 69

4. Valilou, R. H., Rafat, S. A., Notter, D. R., Shojda, D., Moghaddam, G., & Nematollahi, A. (2015). Fecal egg counts for gastrointestinal nematodes are associated with a polymorphism in the MHC-DRB1 gene in the Iranian Ghezel sheep breed. Frontiers in Genetics, 6, 105.
Cited by: 48

5. Pourseif, M. M., Moghaddam, G., Daghighkia, H., Nematollahi, A., & Omidi, Y. (2017). A novel B-and helper T-cell epitopes-based prophylactic vaccine against Echinococcus granulosus. BioImpacts, 8(1), 39–49.
Cited by: 46

Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award

Mr. Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award 

Research Scholar at University of Madras, India

Ragala Venkata Nandha is a passionate young researcher currently pursuing his PhD in Medical Microbiology at Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai. With a strong foundation in microbiological sciences, his work centers on antimicrobial resistance and advanced diagnostic techniques. He holds a Master’s degree in Medical Microbiology and a Bachelor’s in Medical Laboratory Technology. Nandha has contributed to multiple research projects funded by CMRG and RUSA 2.0, addressing clinical microbiology and drug resistance mechanisms. His scientific publications and conference presentations underscore his active engagement in cutting-edge research. As a first and co-author, he has contributed to reputed international journals and book chapters. He is a contributing member of the American Society for Microbiology and actively participates in conferences and workshops. Known for his practical expertise in molecular biology and microbial diagnostics, Nandha is committed to advancing solutions for combating infectious diseases and public health threats.

Professional Profiles

Scopus

Education

Ragala Venkata Nandha is academically trained in the field of microbiology and medical laboratory technology. He is currently enrolled in a PhD program in Medical Microbiology at the Department of Microbiology, Dr. ALM PG IBMS, University of Madras, where he is investigating antimicrobial resistance mechanisms. Prior to his doctoral studies, he earned his Master of Science (M.Sc.) in Medical Microbiology from the same institute, where he conducted research on probiotic enhancement. His undergraduate studies were in Medical Laboratory Technology (B.Sc. MLT) at Dr. NTR University, Vijayawada, Andhra Pradesh. Throughout his academic journey, Nandha has consistently focused on clinical microbiology, diagnostics, and molecular biology. His education has provided him with solid theoretical grounding and extensive hands-on laboratory experience in handling clinical specimens, performing molecular diagnostics, and applying modern research methodologies to real-world medical problems. His academic foundation supports his current research in combating multidrug-resistant pathogens.

Experience

Ragala Venkata Nandha has gained practical and research experience through his roles as a Project Fellow in two major funded research projects. He is currently working as a CMRG Project Fellow in the Department of Genetics at Dr. ALM PG IBMS, University of Madras, where he is developing a multiplex LAMP assay for rapid detection of resistance genes in colistin-resistant Enterobacteriaceae. Prior to this, he served as a RUSA 2.0 Project Fellow, focusing on the neuroimmunoendocrine effects of natural resources in neurodegenerative diseases. His experience includes microbial culture, molecular techniques such as PCR and sequencing, antimicrobial susceptibility testing, and analysis of co-resistance patterns. He also has hands-on training in animal handling and diagnostic laboratory workflows. These roles have enhanced his understanding of translational research and enabled him to contribute significantly to microbiology and infectious disease research at the institutional and national levels.

Research Focus 

Ragala Venkata Nandha’s research is centered on antimicrobial resistance (AMR) and molecular diagnostics. His current PhD project involves the isolation and molecular profiling of carbapenem- and colistin-resistant Gram-negative bacteria from clinical samples. The research aims to understand co-resistance patterns and the evolutionary mechanisms underlying these pathogens. In the CMRG project, he is developing a multiplex LAMP assay to detect mcr-1 to mcr-9 genes responsible for colistin resistance. His postgraduate work explored the prebiotic potential of spinach on probiotic growth, contributing to the understanding of gut microbiota modulation. He has also studied nanotechnology-based antimicrobial agents like eco-friendly silver nanoparticles. His work integrates microbiology, molecular biology, and bioinformatics to address critical healthcare challenges. With expertise in techniques like real-time PCR, Sanger sequencing, and bioinformatics analysis, his goal is to innovate diagnostics and therapeutic strategies for combating drug-resistant infections and improving clinical outcomes.

Publication Top Notes

Title: Advancing beyond conventional vaccines: The potential of next-generation vaccines in combatting antibiotic-resistant bacteria

Journal: Indian Journal of Medical Microbiology

Summary

This article explores the emerging landscape of next-generation vaccines designed to address the growing threat of antibiotic-resistant bacteria. Unlike traditional vaccines, which primarily rely on attenuated or inactivated pathogens, next-gen vaccines leverage novel platforms such as mRNA, recombinant proteins, vector-based systems, and nanoparticle technologies. The paper highlights how these vaccines offer greater specificity, faster development timelines, and adaptability against evolving bacterial strains. It also examines clinical trials, current research trends, and regulatory challenges, emphasizing the crucial role these vaccines play in reducing reliance on antibiotics and slowing antimicrobial resistance (AMR) worldwide.

Conclusion

Ragala Venkata Nandha represents a new generation of focused, skilled, and research-driven microbiologists working at the intersection of clinical diagnostics and antimicrobial resistance. His academic foundation, complemented by ongoing doctoral research, showcases a strong commitment to scientific inquiry and innovation. From molecular biology and nanotechnology to clinical microbiology and bioinformatics, his multidisciplinary approach addresses urgent public health concerns. His contributions as a project fellow, author, and conference presenter reflect both technical expertise and scientific maturity. As a member of international scientific communities and contributor to peer-reviewed literature, he continues to build a credible research profile. With promising achievements in diagnostics development and microbial resistance studies, Nandha is well-positioned to make a lasting impact in translational microbiological research. His journey reflects a dedication not only to academic excellence but also to solving real-world health challenges through research, collaboration, and innovation. He is a valuable asset to the scientific and medical research community.